2023 Q3 Form 10-Q Financial Statement

#000119573423000140 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $120.8M $126.6M
YoY Change 2.65% 9.2%
Cost Of Revenue $32.90M $34.90M
YoY Change -5.5% 6.31%
Gross Profit $87.90M $91.72M
YoY Change 6.11% 10.34%
Gross Profit Margin 72.78% 72.44%
Selling, General & Admin $60.30M $63.89M
YoY Change 1.76% 8.51%
% of Gross Profit 68.6% 69.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.044M $2.887M
YoY Change 4.18% -4.72%
% of Gross Profit 3.46% 3.15%
Operating Expenses $118.1M $123.3M
YoY Change -0.18% 7.28%
Operating Profit $2.631M $3.344M
YoY Change -473.19% 221.23%
Interest Expense $853.0K $1.011M
YoY Change 140.96% 183.19%
% of Operating Profit 32.42% 30.23%
Other Income/Expense, Net
YoY Change
Pretax Income $1.778M $2.333M
YoY Change -80.53% 241.08%
Income Tax $129.0K -$48.00K
% Of Pretax Income 7.26% -2.06%
Net Earnings $1.495M $2.216M
YoY Change -83.44% 286.06%
Net Earnings / Revenue 1.24% 1.75%
Basic Earnings Per Share $0.05 $0.08
Diluted Earnings Per Share $0.05 $0.07
COMMON SHARES
Basic Shares Outstanding 29.32M shares 29.15M shares
Diluted Shares Outstanding 30.03M shares 30.09M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.90M $34.26M
YoY Change 225.06% 133.75%
Cash & Equivalents $30.94M $34.26M
Short-Term Investments
Other Short-Term Assets $5.600M $6.347M
YoY Change 32.54% 63.37%
Inventory $3.600M $3.534M
Prepaid Expenses
Receivables $7.897M $8.275M
Other Receivables $0.00 $0.00
Total Short-Term Assets $48.06M $52.42M
YoY Change 86.93% 77.3%
LONG-TERM ASSETS
Property, Plant & Equipment $45.15M $43.49M
YoY Change 1.08% -4.52%
Goodwill $2.122M $2.122M
YoY Change -4.5% -4.5%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.200M $4.117M
YoY Change 21.04% 18.65%
Total Long-Term Assets $203.2M $204.5M
YoY Change -5.85% -5.43%
TOTAL ASSETS
Total Short-Term Assets $48.06M $52.42M
Total Long-Term Assets $203.2M $204.5M
Total Assets $251.3M $256.9M
YoY Change 4.03% 4.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.955M $9.754M
YoY Change -12.45% 10.03%
Accrued Expenses $32.11M $35.64M
YoY Change 13.45% 11.65%
Deferred Revenue $6.279M $6.626M
YoY Change 2.16% 6.58%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.250M $1.250M
YoY Change -62.5%
Total Short-Term Liabilities $69.85M $74.18M
YoY Change 4.88% 3.28%
LONG-TERM LIABILITIES
Long-Term Debt $20.92M $21.11M
YoY Change 107.11% 12.77%
Other Long-Term Liabilities $4.436M $4.223M
YoY Change 140.69% 120.52%
Total Long-Term Liabilities $25.35M $25.33M
YoY Change 112.29% 22.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $69.85M $74.18M
Total Long-Term Liabilities $25.35M $25.33M
Total Liabilities $241.6M $249.7M
YoY Change 0.41% -1.95%
SHAREHOLDERS EQUITY
Retained Earnings -$336.5M -$338.0M
YoY Change -1.48% -3.59%
Common Stock $460.9M $459.7M
YoY Change 1.22% 1.17%
Preferred Stock
YoY Change
Treasury Stock (at cost) $116.6M $116.5M
YoY Change 1.13% 1.14%
Treasury Stock Shares
Shareholders Equity $9.981M $7.435M
YoY Change
Total Liabilities & Shareholders Equity $251.3M $256.9M
YoY Change 4.03% 4.52%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $1.495M $2.216M
YoY Change -83.44% 286.06%
Depreciation, Depletion And Amortization $3.044M $2.887M
YoY Change 4.18% -4.72%
Cash From Operating Activities $2.480M $12.68M
YoY Change -358.33% 30.48%
INVESTING ACTIVITIES
Capital Expenditures $4.970M $3.969M
YoY Change -376.26% -328.5%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.266M
YoY Change
Cash From Investing Activities -$4.970M -$2.703M
YoY Change 176.26% 55.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -830.0K -1.311M
YoY Change -65.3% -53.44%
NET CHANGE
Cash From Operating Activities 2.480M 12.68M
Cash From Investing Activities -4.970M -2.703M
Cash From Financing Activities -830.0K -1.311M
Net Change In Cash -3.320M 8.665M
YoY Change -35.55% 67.8%
FREE CASH FLOW
Cash From Operating Activities $2.480M $12.68M
Capital Expenditures $4.970M $3.969M
Free Cash Flow -$2.490M $8.710M
YoY Change -396.78% -23.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27395000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1250000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
74175000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
68939000 usd
CY2023Q2 us-gaap Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
1237000 usd
CY2022Q4 us-gaap Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
0 usd
CY2023Q2 pbpb Deferred Financing Costs Deposits And Other Noncurrent Net
DeferredFinancingCostsDepositsAndOtherNoncurrentNet
3368000 usd
CY2022Q4 pbpb Deferred Financing Costs Deposits And Other Noncurrent Net
DeferredFinancingCostsDepositsAndOtherNoncurrentNet
3647000 usd
CY2023Q2 us-gaap Assets
Assets
256873000 usd
CY2022Q4 us-gaap Assets
Assets
245171000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9754000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10718000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35636000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30826000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27535000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21108000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8550000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
150166000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
160968000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4223000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2441000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
249672000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
240898000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29309000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28819000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
389000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
384000 usd
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2219000 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2566000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
459351000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
455831000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10053000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9924000 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
116497000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
115388000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-338027000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-338916000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7435000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4477000 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-234000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-204000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7201000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4273000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
256873000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
245171000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2417000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-7887000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-278000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
120000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
675000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10027000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
708000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-326000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
56000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
820000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8881000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4273000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1204000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-337000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
865000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
2381000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-771000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
96000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
166000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1305000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7201000 usd
us-gaap Profit Loss
ProfitLoss
1178000 usd
us-gaap Profit Loss
ProfitLoss
-7179000 usd
us-gaap Depreciation
Depreciation
5857000 usd
us-gaap Depreciation
Depreciation
6167000 usd
pbpb Noncash Lease Income Expense
NoncashLeaseIncomeExpense
12386000 usd
pbpb Noncash Lease Income Expense
NoncashLeaseIncomeExpense
13020000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-81000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2216000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1495000 usd
pbpb Asset Impairment Store Closure And Disposal Of Property And Equipment
AssetImpairmentStoreClosureAndDisposalOfPropertyAndEquipment
1061000 usd
pbpb Asset Impairment Store Closure And Disposal Of Property And Equipment
AssetImpairmentStoreClosureAndDisposalOfPropertyAndEquipment
2363000 usd
pbpb Gain Loss On Franchise Growth Acceleration Initiative Activities
GainLossOnFranchiseGrowthAccelerationInitiativeActivities
-936000 usd
pbpb Gain Loss On Franchise Growth Acceleration Initiative Activities
GainLossOnFranchiseGrowthAccelerationInitiativeActivities
0 usd
pbpb Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
224000 usd
pbpb Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
209000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
139000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1862000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1379000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-281000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
121000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
240000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-12000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1222000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
455000 usd
pbpb Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-13707000 usd
pbpb Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-14183000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4786000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1180000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12022000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1978000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7281000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3115000 usd
us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
1362000 usd
us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5919000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3115000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2204000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
76000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
961000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
976000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
507000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
176000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13288000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1441000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19391000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
304000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15619000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14353000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35010000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14657000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
245000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
132000 usd
us-gaap Interest Paid Net
InterestPaidNet
1446000 usd
us-gaap Interest Paid Net
InterestPaidNet
236000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1035000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
591000 usd
pbpb Unpaid Liability For Employee Taxes On Certain Stock Based Payment Arrangements
UnpaidLiabilityForEmployeeTaxesOnCertainStockBasedPaymentArrangements
149000 usd
pbpb Unpaid Liability For Employee Taxes On Certain Stock Based Payment Arrangements
UnpaidLiabilityForEmployeeTaxesOnCertainStockBasedPaymentArrangements
97000 usd
CY2023Q2 pbpb Number Of Shops Owns Or Operates By Entity
NumberOfShopsOwnsOrOperatesByEntity
372 shop
CY2023Q2 pbpb Number Of Shops Operate By Franchisees
NumberOfShopsOperateByFranchisees
55 shop
pbpb Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
7 subsidiary
CY2023Q2 pbpb Number Of Joint Ventures
NumberOfJointVentures
6 jointventure
CY2023Q2 pbpb Number Of Joint Ventures
NumberOfJointVentures
6 jointventure
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a 52/53-week fiscal year that ends on the last Sunday of the calendar period. Approximately every five or six years a 53rd week is added. Fiscal year 2023 consists of 53 weeks and fiscal year 2022 consists of 52 weeks. The fiscal quarters ended June 25, 2023 and June 26, 2022 each consisted of 13 weeks. The year to date periods ended June 25, 2023 and June 26, 2022 each consisted of 26 weeks.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities. Significant estimates include amounts for long-lived assets and income taxes. Actual results could differ from those estimates.</span></div>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34261000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15619000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
749000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35010000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15619000 usd
pbpb Revenue Recognition Gift Card Breakage
RevenueRecognitionGiftCardBreakage
400000 usd
pbpb Revenue Recognition Gift Card Breakage
RevenueRecognitionGiftCardBreakage
300000 usd
pbpb Customer Loyalty Program Points Earned Per Dollar Spent
CustomerLoyaltyProgramPointsEarnedPerDollarSpent
10 point
pbpb Customer Loyalty Program Points Required For Loyalty Award
CustomerLoyaltyProgramPointsRequiredForLoyaltyAward
1000 point
pbpb Customer Loyalty Program Expiration Period For Loyalty Reward
CustomerLoyaltyProgramExpirationPeriodForLoyaltyReward
P30D
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7008000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1677000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6626000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3400000 usd
pbpb Increase Decrease In Contract With Customer Liability Current
IncreaseDecreaseInContractWithCustomerLiabilityCurrent
-382000 usd
pbpb Increase Decrease In Contract With Customer Liability Noncurrent
IncreaseDecreaseInContractWithCustomerLiabilityNoncurrent
1723000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5733000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
459000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
465000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
211000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
147000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3011000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10026000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2000000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
700000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1800000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
700000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2216000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
574000 usd
us-gaap Net Income Loss
NetIncomeLoss
890000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7339000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29199000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28565000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29053000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28481000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
467000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
451000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
360000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
422000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
101000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
363000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30088000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29117000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29776000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28481000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
433000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
637000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
633000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1906000 shares
CY2019Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13600000 usd
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M6D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M20D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0844
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0811
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
9982000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
10092000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
20175000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
20397000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
3824000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
3692000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
7364000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
7044000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
62000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
104000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
157000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
214000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
13868000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
13888000 usd
us-gaap Lease Cost
LeaseCost
27696000 usd
us-gaap Lease Cost
LeaseCost
27655000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
10508000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
10804000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
21206000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
21398000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1368000 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6794000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4252000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10176000 usd
CY2023Q2 pbpb Reduction In Operating Right Of Use Assets Due To Lease Terminations And Modifications
ReductionInOperatingRightOfUseAssetsDueToLeaseTerminationsAndModifications
859000 usd
CY2022Q2 pbpb Reduction In Operating Right Of Use Assets Due To Lease Terminations And Modifications
ReductionInOperatingRightOfUseAssetsDueToLeaseTerminationsAndModifications
1264000 usd
pbpb Reduction In Operating Right Of Use Assets Due To Lease Terminations And Modifications
ReductionInOperatingRightOfUseAssetsDueToLeaseTerminationsAndModifications
859000 usd
pbpb Reduction In Operating Right Of Use Assets Due To Lease Terminations And Modifications
ReductionInOperatingRightOfUseAssetsDueToLeaseTerminationsAndModifications
1264000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
20469000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
41337000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
38586000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
34641000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
28906000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
22311000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
46159000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
232409000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
54709000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
177700000 usd
CY2023Q2 pbpb Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
0 usd
CY2023Q2 pbpb Franchise Rent Income
FranchiseRentIncome
500000 usd
pbpb Franchise Rent Income
FranchiseRentIncome
600000 usd
CY2023Q2 pbpb Franchise Lease Expense
FranchiseLeaseExpense
600000 usd
pbpb Franchise Lease Expense
FranchiseLeaseExpense
700000 usd
CY2023Q2 pbpb Lessor Number Of Operating Subleases
LessorNumberOfOperatingSubleases
8 store
CY2022Q2 pbpb Lessor Number Of Operating Subleases
LessorNumberOfOperatingSubleases
0 store
pbpb Lessor Number Of Operating Subleases
LessorNumberOfOperatingSubleases
8 store
pbpb Lessor Number Of Operating Subleases
LessorNumberOfOperatingSubleases
0 store
CY2023Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
480000 usd
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
0 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
600000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
0 usd
CY2023Q2 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
25000 usd
CY2022Q2 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
0 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
38000 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
0 usd
CY2023Q2 pbpb Franchise Rent Income
FranchiseRentIncome
505000 usd
CY2022Q2 pbpb Franchise Rent Income
FranchiseRentIncome
0 usd
pbpb Franchise Rent Income
FranchiseRentIncome
638000 usd
pbpb Franchise Rent Income
FranchiseRentIncome
0 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2017000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
0 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1250000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
21108000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
8550000 usd
CY2023Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1500 rate
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
200000 usd
CY2023Q2 us-gaap Significant Changes Franchises Sold
SignificantChangesFranchisesSold
0 store
CY2022Q2 us-gaap Significant Changes Franchises Sold
SignificantChangesFranchisesSold
0 store
us-gaap Significant Changes Franchises Sold
SignificantChangesFranchisesSold
8 store
us-gaap Significant Changes Franchises Sold
SignificantChangesFranchisesSold
0 store
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
100000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
CY2022Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
512000 usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
CY2023Q2 pbpb Goodwill Written Off Related To Sale Of Shops
GoodwillWrittenOffRelatedToSaleOfShops
0 usd
CY2022Q2 pbpb Goodwill Written Off Related To Sale Of Shops
GoodwillWrittenOffRelatedToSaleOfShops
0 usd
pbpb Goodwill Written Off Related To Sale Of Shops
GoodwillWrittenOffRelatedToSaleOfShops
-21000 usd
pbpb Goodwill Written Off Related To Sale Of Shops
GoodwillWrittenOffRelatedToSaleOfShops
0 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-433000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023Q2 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
0 usd
CY2022Q2 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
0 usd
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-503000 usd
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
0 usd
CY2023Q2 us-gaap Franchisor Costs
FranchisorCosts
14000 usd
CY2022Q2 us-gaap Franchisor Costs
FranchisorCosts
0 usd
us-gaap Franchisor Costs
FranchisorCosts
27000 usd
us-gaap Franchisor Costs
FranchisorCosts
0 usd
CY2023Q2 pbpb Loss On Franchise Growth Acceleration Initiative Activities
LossOnFranchiseGrowthAccelerationInitiativeActivities
14000 usd
CY2022Q2 pbpb Loss On Franchise Growth Acceleration Initiative Activities
LossOnFranchiseGrowthAccelerationInitiativeActivities
0 usd
pbpb Loss On Franchise Growth Acceleration Initiative Activities
LossOnFranchiseGrowthAccelerationInitiativeActivities
963000 usd
pbpb Loss On Franchise Growth Acceleration Initiative Activities
LossOnFranchiseGrowthAccelerationInitiativeActivities
0 usd
CY2023Q1 pbpb Additional Franchises
AdditionalFranchises
13 store
us-gaap Significant Changes Franchises Sold
SignificantChangesFranchisesSold
8 store
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-400000 usd
CY2023Q2 us-gaap Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
1200000 usd
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-500000 usd
CY2023Q2 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
1200000 usd
CY2018Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
65000000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1123589 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
473000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.22
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y5M15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
67000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.77
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
406000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.62
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y21D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
406000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.62
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y21D

Files In Submission

Name View Source Status
0001195734-23-000140-index-headers.html Edgar Link pending
0001195734-23-000140-index.html Edgar Link pending
0001195734-23-000140.txt Edgar Link pending
0001195734-23-000140-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pbpb-20230625.htm Edgar Link pending
pbpb-20230625.xsd Edgar Link pending
pbpb20230625-10qxexx311.htm Edgar Link pending
pbpb20230625-10qxexx312.htm Edgar Link pending
pbpb20230625-10qxexx321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pbpb-20230625_cal.xml Edgar Link unprocessable
pbpb-20230625_def.xml Edgar Link unprocessable
pbpb-20230625_lab.xml Edgar Link unprocessable
pbpb-20230625_pre.xml Edgar Link unprocessable
pbpb-20230625_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending